Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Moss

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Dermatological Treatment|March 13, 2026
Healthcare resource use of patients with mild-moderate psoriasis on systemic treatments: a UK single-center longitudinal retrospective cohort studyElizaveta Gribaleva, Erin Barker, Neil Hansell, et al.
The Canadian Journal of Cardiology|November 25, 2023
The Cost-Effectiveness of First-Line Cryoablation vs First-Line Antiarrhythmic Drugs in Canadian Patients With Paroxysmal Atrial FibrillationJason G Andrade, Joe W E Moss, Malte Kuniss, et al.
Molecular Nutrition & Food Research|May 8, 2023
(+)-Catechin Attenuates Multiple Atherosclerosis-Associated Processes In Vitro, Modulates Disease-Associated Risk Factors in C57BL/6J Mice and Reduces Atherogenesis in LDL Receptor Deficient Mice by Inhibiting Inflammation and Increasing Markers of Plaque StabilityYee-Hung Chan, Joe W E Moss, Jessica O Williams, et al.
BMC Cardiovascular Disorders|July 16, 2024
A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillationMorten Lock Hansen, Joe W E Moss, Jacob Tønnesen, et al.
Food & Function|April 26, 2021
Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high fat dietJoe W E Moss, Jessica O Williams, Wijdan Al-Ahmadi, et al.
Pharmacoeconomics - Open|January 20, 2024
An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation PopulationJoe W E Moss, Derick Todd, Lukasz Grodzicki, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
From protection to amplification: Imperfect chytridiomycosis prophylaxis increases infections in wild amphibiansK M Barnett, T A McMahon, A D Shepack, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Dermatological Treatment|March 13, 2026
Healthcare resource use of patients with mild-moderate psoriasis on systemic treatments: a UK single-center longitudinal retrospective cohort studyElizaveta Gribaleva, Erin Barker, Neil Hansell, et al.
The Canadian Journal of Cardiology|November 25, 2023
The Cost-Effectiveness of First-Line Cryoablation vs First-Line Antiarrhythmic Drugs in Canadian Patients With Paroxysmal Atrial FibrillationJason G Andrade, Joe W E Moss, Malte Kuniss, et al.
Molecular Nutrition & Food Research|May 8, 2023
(+)-Catechin Attenuates Multiple Atherosclerosis-Associated Processes In Vitro, Modulates Disease-Associated Risk Factors in C57BL/6J Mice and Reduces Atherogenesis in LDL Receptor Deficient Mice by Inhibiting Inflammation and Increasing Markers of Plaque StabilityYee-Hung Chan, Joe W E Moss, Jessica O Williams, et al.
BMC Cardiovascular Disorders|July 16, 2024
A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillationMorten Lock Hansen, Joe W E Moss, Jacob Tønnesen, et al.
Food & Function|April 26, 2021
Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high fat dietJoe W E Moss, Jessica O Williams, Wijdan Al-Ahmadi, et al.
Pharmacoeconomics - Open|January 20, 2024
An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation PopulationJoe W E Moss, Derick Todd, Lukasz Grodzicki, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
From protection to amplification: Imperfect chytridiomycosis prophylaxis increases infections in wild amphibiansK M Barnett, T A McMahon, A D Shepack, et al.
Pageof 2